If you've been tracking Rite Aid (NYSE: RAD) in recent weeks, you may have noticed an alarming trend. While its competitor Walgreens Boots Alliance (NASDAQ: WBA) remained a relatively attractive value stock in April as stocks rebounded out of the worst market plunge since the Great Recession, Rite Aid has been all over the map. But well before the coronavirus bear market, investors were concerned about Rite Aid's waning growth indicators.
The company's revenue plunged significantly in the 2018 fiscal year, and things just haven't been the same since. It didn't help matters when a much-anticipated merger with Walgreens came to a screeching halt in 2017, followed by another failed merger with grocery retailer Albertsons in 2018.
Image source: Getty Images.